BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 2006
View Archived Issues
BTG closes busy year
Read More
AZD-2171, combined with chemotherapy or EGFR inhibitor, is active in patients with solid tumors
Read More
Focus on BAY-579352 at ASCO
Read More
ISTA licenses new investigational glaucoma products from Senju
Read More
NeoRx changes name to Poniard Pharmaceuticals
Read More
Epeius awarded grant to support cancer gene therapy trials with Rexin-G
Read More
MQX-503 studied in European trial for Raynaud's phenomenon
Read More
Exenatide snapshots from the American Diabetes Association annual meeting
Read More
Synergistic weight loss seen with bupropion/naltrexone combination
Read More
Galiximab/rituximab combination feasible and active in non-Hodgkin's lymphoma
Read More
GDNF gene therapy is neuroprotective in Huntington's disease / News in Context
Read More
Discovery and potential preclinical antiobesity efficacy of PSN-632408, a GPR119 agonist
Read More
NicOx granted generic name naproxcinod for HCT-3012
Read More
Phase Ia study of Reolysin with radiation completes enrollment
Read More
ARQ-501 enters phase II development
Read More
New phase II study investigates PXD-101 for mesothelioma
Read More
Aeolus selects AEOL-11207 as first development candidate
Read More
New preclinical findings for CF-101
Read More
U.K. acute pain study of cannabinor cleared to begin
Read More
Praecis ceases efforts to license or sell Plenaxis
Read More
Three-hour imaging time point most appropriate for ThromboView
Read More
Immunological bioactivity and antiviral properties of VGV-1 confirmed
Read More
Lenalidomide study snapshots from the European Hematology Association congress
Read More
Study evaluates AVE-7688 pharmacodynamics
Read More
Cardioprotective activity of first generation inhibitor of malonyl-CoA decarboxylase
Read More
Orphan drug designation for Anthim
Read More
Remicade sBLA in psoriatic arthritis accepted for filing
Read More
Recent patents describe new therapeutic strategies for endocrine-related disorders
Read More
Novel antibacterial agents disclosed in two recent Pfizer patents
Read More
New fixed-dose formulations for BPH described in recent GSK patent
Read More